drugset / Trial / NCT02026310

Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment

NCT02026310

Completed 40 enrolled Qifu Li
RandomizedParallel-groupOpen-labelTreatment

Summary

All the guidelines suggest that metformin as the basis of type 2 diabetes medication, and evidence is sufficient.At the same time the basal insulin injection once a day are more and more widely used in diabetes patients in China. This study aims to evaluate the efficacy and safety of adding glimepiride to type 2 diabetes patients with inadequate glycemic control with combined therapy of metformin and basal insulin.

Timeline

Start
2014-01
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule 2 mg
Background Metformin Small molecule
Background insulin glargine Protein / enzyme biologic